These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5531565)

  • 1. [Factors causing decrease in complement activity in chronic liver diseases].
    Tsuji T; Sato M; Nozaki H; Mizuno Y; Kosaka K
    Igaku To Seibutsugaku; 1970 Oct; 81(4):155-61. PubMed ID: 5531565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of complement activity in chronic liver disease].
    Di Simone A; Coraggio F; Riegler G; Ciotola R
    Minerva Dietol Gastroenterol; 1977; 23(3):137-44. PubMed ID: 618090
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum complement and hepatic diseases].
    Kourilsky O; Leroy C; Peltier AP
    Nouv Presse Med; 1973 Jun; 2(25):1720. PubMed ID: 4718548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R; Farini R; Chiaramonte M
    Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of complement (C3) levels in acute hepatitis and chronic liver diseases].
    Soerensen R; Carmona A; Meléndez M; Velasco M
    Rev Med Chil; 1971 Sep; 99(9):630-40. PubMed ID: 5157211
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
    Teisberg P; Gjone E
    Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative correlation between C-reactive protein and other immunity factors in hepatic diseases].
    Pérez Miranda M; Borda Celaya F; Ortíz de Landazúri E
    Rev Clin Esp; 1973 Jun; 130(1):19-28. PubMed ID: 4755582
    [No Abstract]   [Full Text] [Related]  

  • 9. [The C3, C3 Att and C4 fractions of complement in chronic hepatitis: preliminary data].
    Riegler G; Ciotola R; Di Simone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):200-3. PubMed ID: 952675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complement activity in chronic liver diseases].
    Ghidini O; Del Campo A; Tomasi A; Franzoni A
    G Clin Med; 1970 Jul; 51(7):568-79. PubMed ID: 5527274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of immunologic factors in the pathogenesis of chronic active liver diseases].
    Bergiel A
    Przegl Epidemiol; 1974; 28(2):131-7. PubMed ID: 4849657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological problems in chronic liver diseases].
    Bartók I
    Orv Hetil; 1973 Aug; 114(33):1971-5. PubMed ID: 4728404
    [No Abstract]   [Full Text] [Related]  

  • 13. Australia antigen-antibody in hepatitis and other chronic liver disorder.
    Datta DV; Sehgal S; Schorber A
    J Assoc Physicians India; 1981 Jul; 29(7):527-9. PubMed ID: 7328075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoglobulin system and the liver].
    Kühn RA
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):109-11. PubMed ID: 4655068
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryoglobulinemia in chronic liver diseases.
    Shoenfeld Y; Berliner S; Neeman A; Kadish U; Pinkhas J
    Am J Gastroenterol; 1980 Nov; 74(5):439-40. PubMed ID: 7234822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile immunoglobulins in chronic liver diseases.
    Diaz-Rubio Garcia M; Diaz-Rubio Garcia C; Arroyo Ordonez M; Erroz A; Diaz-Rubio M
    Med Chir Dig; 1975; 4(1):21-3. PubMed ID: 1160421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal immunoglobulins in chronic liver diseases].
    Zimmermann S; Kratzsch KH; Lewicki I
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):135-6. PubMed ID: 1021380
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Australia antigen, immunoglobulins and glycoproteins in chronic liver diseases].
    Fehér J; Jakab L; Szilvási I
    Orv Hetil; 1973 Oct; 114(42):2528-31. PubMed ID: 4743664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.